Search result for Mathew Patterson
Astellas set to purchase Audentes Therapeutics Inc. for $3 billion
On Tuesday Astellas Pharma Inc., the Japan-based pharmaceutical firm stated how it had decided on a contract to purchase Audentes Therapeutics Inc., the United States-based biotechnology company, for nearly $3 billion to advance the generation of genetic medicines.
Audentes Therap...